The table below shows CATALYST PHARMACEUTICALS, INC.'s cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Operating cash flow
$208.67M
$239.81M
$143.60M
$116.05M
$60.37M
$45.03M
Capital expenditure
$58.00K
$556.00K
$231.00K
$29.00K
$1.02M
$11.00K
Investing cash flow
-$58.00K
-$556.00K
-$293.50M
$9.21M
-$11.02M
-$5.01M
Dividends paid
-
-
-
-
-
-
CPRX operating cash flow (10-K history)
CATALYST PHARMACEUTICALS, INC. reported operating cash flow of $208.67M for fiscal year 2025. That is down 13.0% from $239.81M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow grew from -$9.88M (FY 2013) to $208.67M. Figures come from the company's audited annual reports as filed with the SEC.
